Genelux Common Stock Price on October 29, 2024
| GNLX Stock | 2.69 0.20 8.03% |
If you're considering investing in Genelux Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genelux Common stands at 2.69, as last reported on the 29th of November, with the highest price reaching 2.70 and the lowest price hitting 2.48 during the day. Genelux Common appears to be slightly risky, given 3 months investment horizon. Genelux Common holds Efficiency (Sharpe) Ratio of 0.0934, which attests that the entity had a 0.0934% return per unit of risk over the last 3 months. By evaluating Genelux Common's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please utilize Genelux Common's Market Risk Adjusted Performance of 0.9981, risk adjusted performance of 0.0775, and Downside Deviation of 5.68 to validate if our risk estimates are consistent with your expectations.
At this time, Genelux Common's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 26.4 M in 2024, whereas Other Stockholder Equity is likely to drop slightly above 181.1 M in 2024. . At this time, Genelux Common's Price To Sales Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 18.45 in 2024, whereas Price Earnings Ratio is likely to drop (12.70) in 2024. Genelux Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Genelux |
Sharpe Ratio = 0.0934
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GNLX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.66 actual daily | 59 59% of assets are less volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Genelux Common is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genelux Common by adding it to a well-diversified portfolio.
Price Book 2.8076 | Enterprise Value Ebitda (327.19) | Price Sales 11.6 K | Shares Float 25.6 M | Wall Street Target Price 18.4 |
Related Headline
Monopar Therapeutics Headline on 29th of October 2024
Three analysts have given Monopar Therapeutics a "Strong Buy" rating. But what does this mean? Analysts don't just rely on technical analysis, which involves studying price momentum, patterns, and trends from past data to gauge market sentiment and predict future movements. Instead, their recommendations often combine both technical and fundamental analysis, considering factors like the company's financial health, product pipeline, and market conditions. While technical analysis can provide insights into investor sentiment, it's just one piece of the puzzle. Let's explore some key elements of Monopar's technical analysis to understand how it might influence investor decisions.
Key Takeaways
Monopar Therapeutics (NASDAQ: MNPR) has been catching attention with its recent news, but a closer look at the technical indicators suggests a more cautious approach. The stock's Coefficient of Variation stands at a high 819.18, indicating significant volatility and potential risk for traders. Despite a Wall Street target price of 18, which suggests a potential upside of 15.92%, the current price percent change of -9.09% signals that the stock is experiencing downward pressure. Additionally, with an operating income loss of 8.8M, investors should weigh these technical factors carefully before making any trading decisions.Genelux Common Valuation on October 29, 2024
It is possible to determine the worth of Genelux Common on a given historical date. On October 29, 2024 Genelux was worth 3.1 at the beginning of the trading date compared to the closed value of 3.09. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genelux Common stock. Still, in general, we apply an absolute valuation method to find Genelux Common's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genelux Common where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genelux Common's related companies.
| Open | High | Low | Close | Volume | |
| 2.56 | 2.98 | 2.56 | 2.96 | 256,849 | |
10/29/2024 | 3.10 | 3.14 | 2.94 | 3.09 | 128,979 |
| 3.05 | 3.50 | 3.04 | 3.33 | 316,220 |
| Backtest Genelux Common | | | Genelux Common History | | | Genelux Common Valuation | Previous | Next |
Genelux Common Trading Date Momentum on October 29, 2024
| On October 30 2024 Genelux Common was traded for 3.33 at the closing time. The top price for the day was 3.50 and the lowest listed price was 3.04 . The trading volume for the day was 316.2 K. The trading history from October 30, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 7.77% . The overall trading delta against the current closing price is 5.50% . |
Genelux Common Fundamentals Correlations and Trends
By evaluating Genelux Common's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genelux Common's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genelux financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Genelux Common Stock history
Genelux Common investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genelux is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genelux Common will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genelux Common stock prices may prove useful in developing a viable investing in Genelux Common
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 24.4 M | 26.4 M | |
| Net Loss | -6 M | -6.3 M |
Genelux Common Stock Technical Analysis
Genelux Common technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Genelux Common Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Genelux Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Genelux Common November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Genelux Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genelux Common shares will generate the highest return on investment. By undertsting and applying Genelux Common stock market strength indicators, traders can identify Genelux Common entry and exit signals to maximize returns
Genelux Common Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Genelux Common's price direction in advance. Along with the technical and fundamental analysis of Genelux Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genelux to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0775 | |||
| Jensen Alpha | 0.5187 | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0831 | |||
| Treynor Ratio | 0.9881 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.